Timothy Craig, DO

home / authors / timothy-craig-do

Professor, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, and Professor, Department of Pediatrics at Penn State University

Articles

June 19th 2025

Garadacimab, Sebetralstat Were Both Safe to Use in Clinical Trials: Timothy Craig, DO

Julia Bonavitacola Timothy Craig, DO

Early trials found that both garadacimab and sebetralstat were safe when used in patients living with hereditary angioedema, which speaks to the promise of the FDA-approved garadacimab.

June 18th 2025

Combination of Garadacimab, Sebetralstat Can Help Patients With HAE: Timothy Craig, DO

Julia Bonavitacola Timothy Craig, DO

The recent approval of garadacimab can help to treat patients with hereditary angioedema (HAE) along with sebetralstat, which is awaiting FDA approval, explains Timothy Craig, DO, Penn State Health.

June 17th 2025

Garadacimab Shuts Down Contact Pathway to Treat HAE: Timothy Craig, DO

Julia Bonavitacola Timothy Craig, DO

With the approval of the FDA, garadacimab can help patients with hereditary angioedema (HAE) prevent attacks by shutting down the contact pathway.